go 6976 has been researched along with etoposide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huigsloot, M; Tijdens, RB; van de Water, B | 1 |
Huang, CY; Huang, EY; Lin, WJ; Lu, YL; Wang, CF; Wang, WL; Yeh, SF | 1 |
2 other study(ies) available for go 6976 and etoposide
Article | Year |
---|---|
Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbazoles; Cell Cycle; Cell Division; Doxorubicin; Drug Interactions; Enzyme Inhibitors; Etoposide; Indoles; Protein Kinase C; Protein Kinase C-alpha; Proto-Oncogene Proteins c-bcl-2; Rats; Tumor Cells, Cultured | 2003 |
Mitochondrial anchoring of PKCalpha by PICK1 confers resistance to etoposide-induced apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carbazoles; Carrier Proteins; Cell Cycle Proteins; Cell Line; Dimerization; Enzyme Inhibitors; Etoposide; Humans; Indoles; Mice; Mitochondria; NIH 3T3 Cells; Nuclear Proteins; Peptides; Protein Kinase C-alpha; Proto-Oncogene Proteins c-bcl-2; Serine | 2007 |